R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions. Inflammatory and Angiogenic Factors at Mid-Pregnancy Are Associated with Spontaneous Preterm Birth in a Cohort of Tanzanian Women. Authors: McDonald C, Darling A, Conroy A, Tran V, Cabrera A, Liles W, Wang M, Aboud S, Urassa W, Fawzi W, Kain K PLoS ONE, 2015;10(8):e0134619. Species: Human Sample Type: Plasma
Biomarkers of Host Response Predict Primary End-Point Radiological Pneumonia in Tanzanian Children with Clinical Pneumonia: A Prospective Cohort Study. Authors: Erdman L, DAcremont V, Hayford K, Rajwans N, Kilowoko M, Kyungu E, Hongoa P, Alamo L, Streiner D, Genton B, Kain K PLoS ONE, 2015;10(9):e0137592. Species: Human Sample Type: Plasma
Differential expression of Vegfr-2 and its soluble form in preeclampsia. Authors: Munaut C, Lorquet S, Pequeux C, Coulon C, Le Goarant J, Chantraine F, Noel A, Goffin F, Tsatsaris V, Subtil D, Foidart JM PLoS ONE, 2012;7(3):e33475. Species: Human Sample Type: Plasma
Serum concentrations of soluble Flt-1 are decreased among women with a viable fetus and no symptoms of miscarriage destined for pregnancy loss. Authors: Kaituu-Lino TJ, Whitehead CL, Ngian GL, Permezel M, Tong S PLoS ONE, 2012;7(2):e32509. Species: Human Sample Type: Serum
Combinations of Host Biomarkers Predict Mortality among Ugandan Children with Severe Malaria: A Retrospective Case-Control Study. Authors: Erdman LK, Dhabangi A, Musoke C, Conroy AL, Hawkes M, Higgins S, Rajwans N, Wolofsky KT, Streiner DL, Liles WC, Cserti-Gazdewich CM, Kain KC PLoS ONE, 2011;6(2):e17440. Species: Human Sample Type: Plasma
Performance characteristics of combinations of host biomarkers to identify women with occult placental malaria: a case-control study from Malawi. Authors: Conroy AL, Liles WC, Molyneux ME PLoS ONE, 2011;6(12):e28540. Species: Human Sample Type: Plasma
Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis. Authors: Hawinkels LJ, Kuiper P, Wiercinska E Cancer Res., 2010;70(10):4141-50. Species: Human Sample Type: Tissue Homogenates
Endoglin (CD105) as a urinary and serum marker of prostate cancer. Authors: Fujita K, Ewing CM, Chan DY, Mangold LA, Partin AW, Isaacs WB, Pavlovich CP Int. J. Cancer, 2009;124(3):664-9. Species: Human Sample Type: Serum
|
背景 | Endoglin (CD105) is a transmembrane type III receptor for TGF-beta superfamily ligands and plays an important role in smooth muscle differentiation, angiogenesis, and neovascularization. It is highly expressed on proliferating vascular endothelial cells, chondrocytes, and syncytiotrophoblasts of term placenta. Human Endoglin haploinsufficiency can a cause the vascular disorder, hereditary hemorrhagic telangiectasia type I. Elevated levels of anti-angiogenic soluble Endoglin contribute to pathogenicity in preeclampsia. Endoglin associates with the receptors TGF-beta RII, Activin RIIA or RIIB, BMPR-IA/ALK-3, or BMPR-IB/ALK6 and enhance binding of Activin A, BMP-2, -7, -9, TGF-beta 1, or TGF-beta 3. Endoglin can either enhance or inhibit signaling through these receptor complexes. |